Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal

MT Newswires Live

07/25

Lisata Therapeutics (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.

Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.

As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.

Price: 1.77, Change: -0.35, Percent Change: -16.51

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2654031755"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2654031755\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2654031755?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-25 02:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654031755","market":"sh","top_or_hot":-1,"title":"Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/LSTA\">Lisata Therapeutics</a> (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.</p><p>Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.</p><p>As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.</p><p>Price: 1.77, Change: -0.35, Percent Change: -16.51</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLisata Therapeutics Shares Fall After Terminating Kuva Labs Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-25 02:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/LSTA\">Lisata Therapeutics</a> (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.</p><p>Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.</p><p>As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.</p><p>Price: 1.77, Change: -0.35, Percent Change: -16.51</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2654031755","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2654031755","pubTimestamp":1784919576,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Lisata Therapeutics  shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.Price: 1.77, Change: -0.35, Percent Change: -16.51","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","LENZ":"Therapeutics","BK4139":"生物科技","LSTA":"LISATA THERAPEUTICS INC","BK4007":"制药"},"translate_title":"Lisata Therapeutics 终止 Kuva Labs 交易后股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LSTA":1,"LENZ":1.5},"content_text":"Lisata Therapeutics (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.Price: 1.77, Change: -0.35, Percent Change: -16.51","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}